{
}
UBS has maintained a 'Neutral' rating for Pfizer, setting a target price of 31 US dollars. Analyst Trung Huynh noted that the pharmaceutical company is starting to regain investor confidence after a mixed performance this year.
UBS has maintained a "Neutral" rating for Pfizer, setting a price target of $31 following a recent conference. Analyst Trung Huynh noted that despite a mixed performance this year, the pharmaceutical company is starting to regain investor confidence.
Pfizer is considering selling its hospital drugs unit, formed after the $17 billion acquisition of Hospira in 2015, amid pressure from activist investor Starboard Value. The unit, which includes various sterile injectables, generates around $500 million in annual EBITDA and could be valued at several billion dollars. This move follows a significant decline in Pfizer's market value and ongoing debt reduction efforts, exacerbated by supply disruptions from a tornado that damaged a key manufacturing facility.
The global healthcare services market is projected to grow from $8,348.44 billion in 2023 to $8,963.64 billion in 2024, driven by advancements in medical technology, an aging population, and health insurance expansion. By 2028, it is expected to reach $10,908.99 billion, with key trends including telemedicine integration and patient-centered care. Shared medical appointments are gaining traction as a cost-effective model for managing chronic conditions, enhancing patient outcomes through collaborative care.
Pharmaceutical giants like Pfizer and Moderna are profiting immensely from Covid-19 vaccines, with combined profits reaching $65,000 per minute. Despite their financial success, they have largely neglected low-income countries, delivering less than 1% of their vaccine stocks to these regions. The People's Vaccine Alliance highlights the urgent need for equitable vaccine distribution to combat "vaccine apartheid."
The global market for premature ejaculation treatment is projected to grow from $3.75 billion in 2024 to $7.59 billion by 2032, driven by increased awareness, innovative treatment options, and the impact of the COVID-19 pandemic on healthcare access. Key players like Pfizer and Eli Lilly are focusing on R&D and collaboration to enhance their market presence. Stigma and cultural barriers remain significant challenges to market growth, despite a rising acceptance of sexual health issues.
Novo Nordisk's Ozempic and Wegovy have transformed from diabetes treatments to weight-loss phenomena, driving the company's revenue to unprecedented heights, with a projected DKK 232 billion in 2023. However, soaring demand has led to shortages, impacting diabetes patients and prompting the company to halt insulin pen distribution in some regions. As Novo Nordisk prepares to launch CagriSema, the global obesity market is expected to reach $37.06 billion by 2031, with GLP-1 receptor agonists dominating.
The Consumer Healthcare Market is witnessing a significant shift towards natural and organic products, driven by consumer demand for safer and environmentally friendly options. This trend reflects growing awareness of the health risks associated with artificial ingredients and the increasing preference for sustainable health solutions. Comprehensive analyses, including Porter's Five Forces and SWOT, provide insights into market dynamics and stakeholder roles, highlighting the evolving landscape of consumer preferences.
At the 7th China International Import Expo in Shanghai, multinational pharmaceutical companies are showcasing innovative medical technologies. Johnson & Johnson launched INVEGA HAFYERA for schizophrenia, while Pfizer presented therapies for atopic dermatitis. GSK highlighted its breakthrough drug Bepirovirsen for chronic hepatitis B and announced a public welfare project for systemic lupus erythematosus patients.
The global healthcare patent filing outsourcing market is projected to grow from USD 1.65 billion in 2024 to USD 2.54 billion by 2034, with a CAGR of 4.4%. The pharmaceutical segment leads with 50.4% market share, driven by significant R&D investments, while the medtech segment is expected to grow the fastest. North America dominates the market, but Asia Pacific is emerging rapidly due to its expanding healthcare industries and increasing patent filings.
Pfizer Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains neutral rating for pfizer with target price of 31 dollars
12:30 14.11.2024
UBS maintains neutral rating for Pfizer with price target of 31 dollars
11:42 14.11.2024
Pfizer considers divesting hospital drugs unit amid investor pressure and debt concerns
United States Dollar
The Goldman Sachs Group, Inc.
ICU Medical, Inc.
Pfizer Inc.
USA
Dave Denton
Albert Bourla
Show more
17:09 12.11.2024
global healthcare services market poised for significant growth through 2028
United States Dollar
Community Health Systems, Inc.
UnitedHealth Group Incorporated
CVS Health Corporation
Regeneron Pharmaceuticals, Inc.
Cardinal Health, Inc.
Fresenius Medical Care AG & Co. KGaA
Centene Corporation
Baxter International Inc.
Mayo Clinic
Agilent Technologies, Inc.
Johnson & Johnson
Pfizer Inc.
Cleveland Clinic Global Solutions LLC
McKesson Corporation
Merck & Co., Inc.
Abbott Laboratories
Bristol-Myers Squibb Company
Quest Diagnostics Incorporated
HCA Healthcare, Inc.
Gilead Sciences, Inc.
Kaiser Permanente Group Trust
Cigna Corporation
Stryker Corporation
Tenet Healthcare Corporation
Danaher Corporation
AbbVie Inc.
Boston Scientific Corporation
Molina Healthcare, Inc.
Align Technology, Inc.
AmerisourceBergen Corporation
Laboratory Corporation OF America Holdings
DaVita Inc.
Eli Lilly and Company
Humana Inc.
West Pharmaceutical Services, Inc.
Fresenius Medical Care AG & Co. KGaA
Kaiser Permanente
UnitedHealth Group Incorporated
Tenet Healthcare
HCA Healthcare
Show more
20:40 11.11.2024
pharmaceutical industry scandals and lobbying influence on public health decisions
United States Dollar
Novartis AG
Merck & Co., Inc.
Moderna, Inc.
GlaxoSmithKline
Pfizer Inc.
Takeda
AbbVie Inc.
Bristol Meyers
Sanofi
Hoffmann-La Roche AG
Johnson & Johnson
USA
Jean-François Delfraissy
Christian Perronne
Arnaud Fontanet
Robert Malone
Didier Raoult
Show more
15:20 11.11.2024
Global Market for Premature Ejaculation Treatment Expected to Reach 7.59 Billion by 2032
Vivus
Novartis AG
Johnson & Johnson
GLAXOSMITHKLINE CAPITAL PLC 4.0
Teva
Torrent Pharmaceuticals Limited
Bayer AG
Sunrise Pharma
Eli Lilly and Co
REGENT PACIFIC
Pfizer Inc.
USA
CAN
Eli Lilly
Brian Johnson
Show more
09:00 11.11.2024
Novo Nordisk's weight loss drugs drive soaring demand and market shortages
Danish Krone
United States Dollar
Euro
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Eli Lilly and Company
Chiesi Farmaceutici S.p.A.
USA
ITA
ZAF
DNK
Elon Musk
Joe Biden
Andy Cohen
Show more
15:00 10.11.2024
consumer healthcare market trends highlight rising demand for natural products
Bayer AG
Johnson & Johnson
GlaxoSmithKline plc (GSK)
Sanofi
Pfizer Inc.
The Procter & Gamble Company
Sanofi S.A.
Johnson & Johnson
GlaxoSmithKline plc
Bayer AG
Pfizer Inc.
Show more
09:04 08.11.2024
drug companies showcase innovations at china international import expo
United States Dollar
GSK plc
Pfizer Inc.
Johnson & Johnson
CHN
Johnson & Johnson
Edward Zhou
Zhou Wenting
Show more
12:56 07.11.2024
global healthcare patent filing outsourcing market projected to reach 2.54 billion by 2034
12:25 07.11.2024
Trending
Subcategory
Corporate News
Industry Trends
Stock Market Updates
Retail and Consumer Goods
Global Financial Events
Finance Mergers & Acquisitions
Global Trade Developments
Central Bank Actions
Industry Mergers & Acquisitions
Banking Regulations
CEO Changes
Startups & Entrepreneurship
Market Analysis and Predictions
Supply Chain Management
Financial Scams and Security
Workplace Trends
Government Economic Policies
Energy Sector Developments
AI Innovations
Cryptocurrency Trends
Countries:
Companies:
The Goldman Sachs Group, Inc.
Bank of America Corporation
Apple Inc.
Barclays PLC
Wells Fargo & Company
Tesla, Inc.
Alphabet Inc.
Citigroup Inc.
Lloyds Banking Group plc
Deutsche Bank RV Global PP
PepsiCo, Inc.
Commerzbank AG
Google Inc.
NatWest Group plc
BNP Paribas SA
Morgan Stanley
UBS Group AG
NVIDIA Corporation
Amazon.com, Inc.
JPMorgan Chase & Co.
Currencies:
United States Dollar
Euro
British Pound Sterling
Chinese Yuan
Swiss Franc
Indian Rupee
Japanese Yen
Indonesian Rupiah
Canadian Dollar
Russian Ruble
South Korean Won
United Arab Emirates Dirham
Offshore Chinese Yuan
Ghanaian Cedi
Hungarian Forint
Albanian Lek
Brazilian Real
Singapore Dollar
Qatari Riyal
Jordanian Dinar
People: